Mill Creek Capital Advisors, LLC Precigen, Inc. Transaction History
Mill Creek Capital Advisors, LLC
- $4.81 Billion
- Q3 2025
A detailed history of Mill Creek Capital Advisors, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Mill Creek Capital Advisors, LLC holds 150,000 shares of PGEN stock, worth $691,500. This represents 0.01% of its overall portfolio holdings.
Number of Shares
150,000
Previous 255,000
41.18%
Holding current value
$691,500
Previous $362,000
36.19%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding PGEN
# of Institutions
188Shares Held
194MCall Options Held
6.61MPut Options Held
2.06M-
Third Security, LLC83.5MShares$385 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD26.5MShares$122 Million4.02% of portfolio
-
Tang Capital Management LLC San Diego, CA12.4MShares$57.2 Million1.85% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$47.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.94MShares$41.2 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $960M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...